Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution-Reference-Cited by-同舟云学术

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution

Published:2017-07-05 Issue:6 Volume:22 Page:1087-1093
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Fujita Naoki,Koie Takuya,Ohyama Chikara,Tanaka Yoshimi,Soma Osamu,Matsumoto Teppei,Yamamoto Hayato,Imai Atsushi,Tobisawa Yuki,Yoneyama Tohru,Hatakeyama Shingo,Hashimoto Yasuhiro

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/article/10.1007/s10147-017-1160-8/fulltext.html

Reference27 articles.

1. Lester-Coll NH, Goldhaber SZ, Sher DJ et al (2013) Death from high-risk prostate cancer versus cardiovascular mortality with hormone therapy. Cancer 119:1808–1815

2. Yuh B, Artibani W, Heidenreich A et al (2013) The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review. Eur Urol 65:918–927

3. Yossepowitch O, Eggener SE, Serio AM et al (2008) Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. Eur Urol 53:950–959

4. Loeb S, Schaeffer EM, Trock BJ et al (2010) What are the outcomes of radical prostatectomy for high-risk prostate cancer? Urology 76:710–714

5. Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65:124–137

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in high-risk localized prostate cancer: Staging and management;Current Problems in Cancer;2023-08

2. Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients;Journal of Robotic Surgery;2023-07-19

3. Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer;Life;2023-04-23

4. Clinical factors associated with biochemical recurrence of prostate cancer with seminal vesicle invasion followed by robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group);Journal of Robotic Surgery;2023-03-16

5. Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-05-11